• AAPL 167.04
  • TSLA 149.9
  • AMZN 179.17
  • MSFT 404.33
  • INTC 35.04
  • EURUSD 1.0635
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MX /
  3. DANHOS13.MX

Fibra Danhos (DANHOS13 MX) stock market data APIs

₱20.18 -0.21(-1%) as of April 18, 2024

Fibra Danhos Financial Data Overview

20.39
20.18
-
20.71
20.15
18.8279-24
31 544 M
10.3385
1 565 M
6 186 M
0.552
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'DANHOS13',
Type: 'Common Stock',
Name: 'Fibra Danhos',
Exchange: 'MX',
CurrencyCode: 'MXN',
CurrencyName: 'Mexican Peso',
CurrencySymbol: '₱',
CountryName: 'Mexico',
CountryISO: 'MX',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Real Estate',
Industry: 'REIT - Diversified',
}

Fibra Danhos Fundamental Data is available in our Financial Data APIs

  • Net Revenue 6 186 M
  • EBITDA 3 956 M
  • Earnings Per Share 1.95
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Fibra Danhos Earnings via APIs

  • Latest Release 2024-04-19
  • EPS/Forecast NaN

Get Fibra Danhos End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Fibra Danhos latest news via APIs

Jounce dumps Redx Pharma for acquisition by Concentra; to cut 84% of jobs

March 27 (Reuters) - Jounce Therapeutics Inc on Monday agreed to be acquired by privately held Concentra Biosciences for $96.46 million, while spurning a merger deal with British biotech firm Redx Pha...
  • JOUNCE THERAPEUTICS
  • REDX PHARMA

Jounce (JNCE) Up 41% on Buyout Offer From Concentra Biosciences

Shares of Jounce Therapeutics JNCE were up 40.6% on Mar 15 after management announced that Concentra Biosciences (“Concentra”) had made an unsolicited and non-binding proposal to acquire the compa...
  • CASH AND CASH EQUIVALENTS
  • CONCENTRA
  • CRISPR THERAPEUTICS
  • INC
  • JOUNCE THERAPEUTICS
  • ZACKS INVESTMENT RESEARCH
Do you have any questions?
support@eodhistoricaldata.com